Last Friday brought a slew of updates from ASX-listed Australian medicinal cannabis companies looking to finance their next stages of growth.
Bod Australia announced it had received firm commitments to undertake a A$8 million placement having entered into a trading halt a day earlier. It will use the money to accelerate product launches and expand internationally.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.